• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cedara Software faces Nasdaq delisting

Article

The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either

The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either the net tangible assets or minimum stockholders' equity requirements for continued listing on the exchange. The company intends to request a hearing before a Nasdaq listing qualifications panel to review the decision.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.